Surgery Financial Statements From 2010 to 2024

Stocks USA . 
Stock . Surgery Partners
SGRY Stock  USD 26.45  0.62  2.29%   
Surgery Partners financial statements provide useful quarterly and yearly information to potential Surgery Partners investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Surgery Partners financial statements helps investors assess Surgery Partners' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Surgery Partners' valuation are summarized below:
Gross Profit
574.9 M
Profit Margin
0.0002
Market Capitalization
3.4 B
Enterprise Value Revenue
2.2598
Revenue
2.8 B
We have found one hundred twenty available fundamental trend indicators for Surgery Partners, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Surgery Partners current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 3.7 B in 2024, whereas Enterprise Value is likely to drop slightly above 1.9 B in 2024.

Surgery Partners Total Revenue

1.59 Billion

Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery main balance sheet or income statement drivers, such as Depreciation And Amortization of 79 M, Interest Expense of 151.6 M or Selling General Administrative of 80.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
This module can also supplement Surgery Partners' financial leverage analysis and stock options assessment as well as various Surgery Partners Technical models . Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Surgery Partners Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding131.9 M125.6 M56.5 M
Slightly volatile
Total Assets4.6 B7 B3.5 B
Slightly volatile
Short and Long Term Debt Total2.5 B3.1 B1.9 B
Slightly volatile
Other Current Liabilities241.5 M235.1 M180.2 M
Slightly volatile
Total Current Liabilities371.2 M523 M280.7 M
Slightly volatile
Other Liabilities38.2 M40.2 M117 M
Slightly volatile
Property Plant And Equipment Net641.9 M1.2 B474.9 M
Slightly volatile
Net Debt2.3 B2.9 B1.8 B
Slightly volatile
Accounts Payable97.5 M177 M75.1 M
Slightly volatile
Cash185.4 M195.9 M138.6 M
Slightly volatile
Non Current Assets Total4 B6.1 B3 B
Slightly volatile
Non Currrent Assets Other44.3 M28.7 M33.5 M
Slightly volatile
Other Assets133.6 M140.6 M455.8 M
Slightly volatile
Long Term Debt2.2 B2.7 B1.7 B
Slightly volatile
Cash And Short Term Investments185.4 M195.9 M138.6 M
Slightly volatile
Net Receivables333.7 M513.6 M255.8 M
Slightly volatile
Good Will3.1 B4.3 B2.3 B
Slightly volatile
Liabilities And Stockholders Equity4.6 B7 B3.5 B
Slightly volatile
Non Current Liabilities Total2.6 B3.1 B2 B
Slightly volatile
Inventory48.1 M75.2 M36.2 M
Slightly volatile
Other Current Assets77.2 M110.3 M58.2 M
Pretty Stable
Other Stockholder Equity2.6 B2.5 B771.7 M
Slightly volatile
Total Liabilities4.3 B3.7 B3.2 B
Slightly volatile
Property Plant And Equipment Gross1.8 B1.7 B623 M
Slightly volatile
Total Current Assets626.5 M895 M475.9 M
Slightly volatile
Short Term Debt70.8 M110.9 M53.7 M
Slightly volatile
Intangible Assets53.2 M54.8 M44.4 M
Slightly volatile
Property Plant Equipment1.4 B1.3 B532.1 M
Slightly volatile
Long Term Investments99.2 M184.1 M75.7 M
Slightly volatile
Short and Long Term Debt55.9 M73.3 M43.5 M
Slightly volatile
Common Stock761.8 K1.5 M654 K
Slightly volatile
Warrants673 M393.3 M458.5 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity724.6 M1.1 B572.5 M
Slightly volatile
Common Stock Total Equity1.4 M1.5 M56 M
Pretty Stable
Short Term Investments108.7 M103.5 M50.7 M
Slightly volatile
Long Term Debt Total2.5 B2.9 B2 B
Slightly volatile
Capital Surpluse3 B2.8 B986.7 M
Slightly volatile
Non Current Liabilities Other79.6 M41.1 M93.5 M
Very volatile
Deferred Long Term Asset Charges115.3 M125.6 M104.5 M
Slightly volatile
Capital Lease Obligations267.9 M286.5 M169.5 M
Slightly volatile
Net Invested Capital3.6 B4.8 B3.1 B
Slightly volatile
Net Working Capital326.9 M372 M281.9 M
Slightly volatile
Capital Stock1.1 M1.2 M271.6 M
Slightly volatile

Surgery Partners Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization79 M118.1 M64.2 M
Slightly volatile
Interest Expense151.6 M227.7 M124.2 M
Slightly volatile
Selling General Administrative80.8 M120.9 M67.5 M
Slightly volatile
Total Revenue1.6 B2.7 B1.3 B
Slightly volatile
Gross Profit377.3 M529.4 M313 M
Slightly volatile
Other Operating Expenses1.4 B2.3 B1.1 B
Slightly volatile
Operating Income209.5 M408.5 M174.4 M
Slightly volatile
EBIT228.9 M408.5 M189.9 M
Slightly volatile
EBITDA307.9 M526.6 M254.1 M
Slightly volatile
Cost Of Revenue1.2 B2.2 B985.5 M
Slightly volatile
Total Operating Expenses137.1 M120.9 M114.1 M
Slightly volatile
Non Recurring1.4 M1.4 M35.4 M
Pretty Stable
Interest Income141.9 M205.7 M135.6 M
Slightly volatile
Reconciled Depreciation97.6 M116.6 M72.1 M
Slightly volatile

Surgery Partners Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.5 M17.7 M7.6 M
Slightly volatile
Free Cash Flow215.2 M205 M86.9 M
Slightly volatile
Begin Period Cash Flow152 M282.9 M121.4 M
Slightly volatile
Depreciation67.3 M118.1 M54.9 M
Slightly volatile
Other Non Cash Items246.9 M235.1 M77.3 M
Slightly volatile
Capital Expenditures46.2 M88.8 M37.3 M
Slightly volatile
Total Cash From Operating Activities308.5 M293.8 M127.3 M
Slightly volatile
End Period Cash Flow160.9 M195.9 M128.4 M
Slightly volatile
Change To Netincome54.4 M41.3 M70.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.521.46481.6718
Slightly volatile
Dividend Yield0.00140.00150.0499
Slightly volatile
Days Sales Outstanding83.8668.335275.7304
Pretty Stable
Free Cash Flow Yield0.0650.0510.0755
Pretty Stable
Operating Cash Flow Per Share1.732.33891.9701
Slightly volatile
Stock Based Compensation To Revenue0.00390.00650.0044
Slightly volatile
EV To Sales2.962.50943.1055
Slightly volatile
Free Cash Flow Per Share1.171.6321.3638
Pretty Stable
Inventory Turnover21.7129.440228.7853
Slightly volatile
Days Of Inventory On Hand16.2812.39813.9043
Very volatile
Payables Turnover10.4312.507912.1169
Slightly volatile
Sales General And Administrative To Revenue0.0660.04410.0653
Slightly volatile
Cash Per Share2.241.55962.2548
Slightly volatile
POCF Ratio17.313.677216.3703
Pretty Stable
Interest Coverage1.571.7941.5305
Slightly volatile
PFCF Ratio23.5819.601828.0747
Pretty Stable
Days Payables Outstanding33.4229.181532.3653
Slightly volatile
EV To Operating Cash Flow39.0423.431134.048
Very volatile
EV To Free Cash Flow54.0933.580859.1035
Pretty Stable
Intangibles To Total Assets0.760.62410.7114
Slightly volatile
Net Debt To EBITDA8.445.44197.1926
Very volatile
Current Ratio1.911.71131.7921
Slightly volatile
Receivables Turnover3.985.34134.9365
Very volatile
Graham Number8.885.8079.3359
Slightly volatile
Revenue Per Share19.3921.839321.402
Slightly volatile
Interest Debt Per Share32.7318.88534.095
Slightly volatile
Debt To Assets0.290.30550.6253
Slightly volatile
Enterprise Value Over EBITDA14.5613.072713.916
Slightly volatile
Short Term Coverage Ratios2.772.64923.1409
Slightly volatile
Operating Cycle10080.733289.6347
Very volatile
Days Of Payables Outstanding33.4229.181532.3653
Slightly volatile
Price To Operating Cash Flows Ratio17.313.677216.3703
Pretty Stable
Price To Free Cash Flows Ratio23.5819.601828.0747
Pretty Stable
Operating Profit Margin0.150.14890.1563
Slightly volatile
Long Term Debt To Capitalization0.990.50580.9909
Slightly volatile
Total Debt To Capitalization0.990.5190.9908
Slightly volatile
Return On Capital Employed0.06610.06290.0754
Slightly volatile
Ebit Per Revenue0.150.14890.1563
Slightly volatile
Quick Ratio1.581.35661.4829
Slightly volatile
Cash Ratio0.370.37460.4269
Slightly volatile
Cash Conversion Cycle66.7351.551757.2701
Pretty Stable
Operating Cash Flow Sales Ratio0.110.10710.1102
Slightly volatile
Days Of Inventory Outstanding16.2812.39813.9043
Very volatile
Days Of Sales Outstanding83.8668.335275.7304
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.730.69780.698
Slightly volatile
Cash Flow Coverage Ratios0.140.1370.0811
Very volatile
Fixed Asset Turnover2.132.24135.9109
Slightly volatile
Price Cash Flow Ratio17.313.677216.3703
Pretty Stable
Enterprise Value Multiple14.5613.072713.916
Slightly volatile
Debt Ratio0.290.30550.6253
Slightly volatile
Cash Flow To Debt Ratio0.140.1370.0811
Very volatile
Price Sales Ratio1.521.46481.6718
Slightly volatile
Asset Turnover0.430.39080.434
Slightly volatile
Gross Profit Margin0.30.1930.2915
Slightly volatile

Surgery Partners Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.7 B3.5 B1.9 B
Slightly volatile
Enterprise Value1.9 B2.5 B2.3 B
Slightly volatile

Surgery Fundamental Market Drivers

Forward Price Earnings23.6967
Cash And Short Term Investments195.9 M

Surgery Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Surgery Partners Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Surgery Partners income statement, its balance sheet, and the statement of cash flows. Surgery Partners investors use historical funamental indicators, such as Surgery Partners's revenue or net income, to determine how well the company is positioned to perform in the future. Although Surgery Partners investors may use each financial statement separately, they are all related. The changes in Surgery Partners's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgery Partners's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Surgery Partners Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.7 M3.9 M
Total Revenue2.7 B1.6 B
Cost Of Revenue2.2 B1.2 B
Stock Based Compensation To Revenue 0.01  0 
Sales General And Administrative To Revenue 0.04  0.07 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue(0.03)(0.03)
Revenue Per Share 21.84  19.39 
Ebit Per Revenue 0.15  0.15 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
CRMSalesforce
MSFTMicrosoft
When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:
How To Invest In Surgery
Details
Is Surgery Stock a good investment?
Details
What is Surgery Partners' Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Surgery Stock analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.01
Revenue Per Share
22.213
Quarterly Revenue Growth
0.077
Return On Assets
0.04
Return On Equity
0.0476
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY